# FDA 483 - Cameron G. Javid, M.D. - February 16, 2023

Source: https://www.keypedia.com/records/483/cameron-g-javid-md/61064e70-af10-4ce7-bd60-04a31f395959

> FDA 483 for Cameron G. Javid, M.D. on February 16, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cameron G. Javid, M.D.
- Inspection Date: 2023-02-16
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Cameron G. Javid, M.D., a clinical investigator in Tucson, AZ, revealed a significant deficiency in maintaining adequate and accurate case histories. Specifically, adverse events and concomitant medications noted in source documents were either inactivated or not included in electronic case report forms for a reviewed protocol. This indicates a failure to ensure complete and accurate data pertinent to the investigation.

## Related Officers

- [Julian C. Hanson](https://www.keypedia.com/people/julian-c-hanson/489e27d9-0de6-4bf0-8aec-e5d500841f52)

Company: https://www.keypedia.com/companies/cameron-g-javid-md/1f4fce5d-dff7-4ce1-b907-0a5c5f542661

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face